Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease

被引：20

作者：

Frey, Sarah ^{[1
]}

Chiang, Teresa Po-Yu ^{[1
]}

Connolly, Caoilfhionn M. ^{[2
]}

Teles, Mayan ^{[1
]}

Alejo, Jennifer L. ^{[1
]}

Boyarsky, Brian J. ^{[1
]}

Christopher-Stine, Lisa ^{[2
]}

Werbel, William A. ^{[3
]}

Massie, Allan B. ^{[1
]}

Segev, Dorry L. ^{[1
,4
]}

Paik, Julie J. ^{[2
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Dept Med, Dept Surg, Baltimore, MD 21224 USA

[2] Johns Hopkins Univ, Sch Med, Dept Med, Div Rheumatol, Baltimore, MD 21224 USA

[3] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21224 USA

[4] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept, Baltimore, MD USA

来源：

LANCET RHEUMATOLOGY | 2022年 / 4卷 / 04期

关键词：

D O I：

10.1016/S2665-9913(21)00417-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E241 / E243

页数：3

共 10 条

[1] Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies [J].

Boekel, Laura ;

Steenhuis, Maurice ;

Hooijberg, Femke ;

Besten, Yaelle R. ;

van Kempen, Zoe L. E. ;

Kummer, Laura Y. ;

van Dam, Koos P. J. ;

Stalman, Eileen W. ;

Vogelzang, Erik H. ;

Cristianawati, Olvi ;

Keijzer, Sofie ;

Vidarsson, Gestur ;

Voskuyl, Alexandre E. ;

Wieske, Luuk ;

Eftimov, Filip ;

van Vollenhoven, Ronald ;

Kuijpers, Taco W. ;

van Ham, S. Marieke ;

Tas, Sander W. ;

Killestein, Joep ;

Boers, Maarten ;

Nurmohamed, Michael ;

Rispens, Theo ;

Wolbink, Gertjan .

LANCET RHEUMATOLOGY, 2021, 3 (11) :E778-E788

[2]

Centers for Disease Control and Prevention, COVID 19 VACC BOOST

[3] Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series [J].

Connolly, Caoilfhionn M. ;

Boyarsky, Brian J. ;

Ruddy, Jake A. ;

Werbel, William A. ;

Christopher-Stine, Lisa ;

Garonzik-Wang, Jacqueline M. ;

Segev, Dorry L. ;

Paik, Julie J. .

ANNALS OF INTERNAL MEDICINE, 2021, 174 (09) :1332-+

[4] Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19 [J].

Doria-Rose, Nicole ;

Suthar, Mehul S. ;

Makowski, Mat .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (23) :2259-2261

[5] Antibody kinetics in patients with rheumatic diseases after SARS- CoV-2 mRNA vaccination [J].

Frey, Sarah ;

Connolly, Caoilfhionn M. ;

Chiang, Teresa Po-Yu ;

Teles, Mayan ;

Alejo, Jennifer L. ;

Boyarsky, Brian J. ;

Christopher-Stine, Lisa ;

Werbel, William A. ;

Segev, Dorry L. ;

Paik, Julie J. .

LANCET RHEUMATOLOGY, 2021, 3 (11) :E753-E754

[6] Quantitative Measurement of Anti-SARS-CoV-2 Antibodies: Analytical and Clinical Evaluation [J].

Higgins, Victoria ;

Fabros, Anselmo ;

Kulasingam, Vathany .

JOURNAL OF CLINICAL MICROBIOLOGY, 2021, 59 (04)

[7] Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection [J].

Khoury, David S. ;

Cromer, Deborah ;

Reynaldi, Arnold ;

Schlub, Timothy E. ;

Wheatley, Adam K. ;

Juno, Jennifer A. ;

Subbarao, Kanta ;

Kent, Stephen J. ;

Triccas, James A. ;

Davenport, Miles P. .

NATURE MEDICINE, 2021, 27 (07) :1205-+

[8] High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases [J].

Ruddy, Jake A. ;

Connolly, Caoilfhionn Marie ;

Boyarsky, Brian J. ;

Werbel, William A. ;

Christopher-Stine, Lisa ;

Garonzik-Wang, Jacqueline ;

Segev, Dorry L. ;

Paik, Julie J. .

ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (10) :1351-+

[9]

US Food and Drug Administration, 2021, FDA BRIEF FDA UPD EM

[10]

US Food & Drug Administration, 2021, Compliance Policy Guide Sec. 570.375 Aflatoxins in Peanuts and Peanut Products: Guidance for FDA Staff

← 1 →